Appili Therapeutics Inc Total Liabilities

Latest as of December 2025: CA$16.93 Million CAD ≈ $12.25 Million USD

Appili Therapeutics Inc total liabilities. Based on the latest financial reports, Appili Therapeutics Inc (APLI) has total liabilities worth CA$16.93 Million CAD (≈ $12.25 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Appili Therapeutics Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Appili Therapeutics Inc (2017–2025)

Total liabilities of Appili Therapeutics Inc from 2017 to 2025. This chart illustrates how Appili Therapeutics Inc's total liabilities have evolved over time, based on quarterly financial data.

Appili Therapeutics Inc Competitors by Total Liabilities

The table below lists competitors of Appili Therapeutics Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Watkin Jones PLC LSE:WJG	UK	GBX165.03 Million
Jersey Oil and Gas PLC LSE:JOG	UK	GBX239.99K
MOVEBYBIKE EUROPE AB F:6ZR	Germany	€13.22 Million
Reliance Industries Limited IL:RIGD	UK	$10.92 Trillion
Setubandhan Infrastructure Limited NSE:SETUINFRA	India	Rs2.29 Billion
Naked Wines plc LSE:WINE	UK	GBX107.52 Million
Purple Biotech Ltd TA:KTOV	Israel	ILA29.64 Million
SECITS Holding AB (publ) ST:SECI	Sweden	Skr83.32 Million

Liability Composition Analysis (2017–2025)

This chart breaks down Appili Therapeutics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Appili Therapeutics Inc.

Liquidity & Leverage Metrics

Appili Therapeutics Inc Total Liabilities Ratios Explained

Appili Therapeutics Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.03	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.03	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	30.90	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Appili Therapeutics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Appili Therapeutics Inc (2017–2025)

The table below shows the annual total liabilities of Appili Therapeutics Inc from 2017 to 2025.

Year	Total Liabilities	Change
2025-03-31	CA$16.43 Million ≈ $11.89 Million	+32.34%
2024-03-31	CA$12.42 Million ≈ $8.98 Million	+17.91%
2023-03-31	CA$10.53 Million ≈ $7.62 Million	-8.85%
2022-03-31	CA$11.55 Million ≈ $8.36 Million	+107.62%
2021-03-31	CA$5.56 Million ≈ $4.02 Million	+138.96%
2020-03-31	CA$2.33 Million ≈ $1.68 Million	-3.59%
2019-03-31	CA$2.42 Million ≈ $1.75 Million	+3.95%
2018-03-31	CA$2.32 Million ≈ $1.68 Million	+94.78%
2017-03-31	CA$1.19 Million ≈ $862.92K	--

About Appili Therapeutics Inc

TO:APLI Canada Biotechnology

Market Cap

$464.29K

CA$641.83K CAD

Market Cap Rank

#31103 Global

#1645 in Canada

Share Price

CA$0.01

Change (1 day)

-50.00%

52-Week Range

CA$0.01 - CA$0.03

All Time High

CA$1.87